Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 11.50
-0.24 (-2.04%)
At close: Sep 24, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 535.18 million as of September 24, 2026. Its market cap has decreased by -31.95% in one year.
Market Cap
535.18M
Enterprise Value
201.94M
Revenue
35.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.50
ChartMarket Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 535.18M, a decrease of -64.73%. That is a compound annual growth rate of -36.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 535.18M | -40.29% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.32B |
| Nanexa AB | 1.03B |
| Dicot Pharma AB | 780.46M |
| EQL Pharma AB | 685.09M |
| Moberg Pharma AB | 514.27M |
| Orexo AB | 440.01M |
| Enzymatica AB | 412.65M |
| Klaria Pharma Holding AB (publ.) | 145.62M |